tiprankstipranks
Advertisement
Advertisement

Scilex Plans Major Investment in Datavault Quantum-Ready Network

Story Highlights
  • Scilex signed a binding term sheet on April 26, 2026 with Datavault to fund a $120 million quantum-ready GPU network across about 100 U.S. cities, in exchange for a long-term, tiered share of network revenues up to $1.2 billion and beyond.
  • The agreement remains preliminary and subject to definitive documentation, regulatory and board approvals, and Datavault’s performance, with Scilex cautioning that failure to close or related disputes could strain liquidity and introduce added risk for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Scilex Plans Major Investment in Datavault Quantum-Ready Network

Claim 55% Off TipRanks

The latest update is out from Scilex Holding Company ( (SCLX) ).

On April 26, 2026, Scilex Holding Company entered into a binding term sheet with Datavault AI Inc. for a proposed cash contribution and revenue participation deal tied to Datavault’s planned quantum-ready GPU infrastructure across about 100 U.S. cities. Scilex expects to contribute $120 million in multiple closings by December 31, 2026, with proceeds earmarked solely for building out the Quantum-Ready Edge Network, while Datavault would share a tiered portion of network revenues with Scilex up to $1.2 billion and 5% thereafter over the GPUs’ operating life.

The term sheet, governed by Delaware law, outlines customary representations, covenants, and termination provisions, but remains subject to negotiation of definitive agreements, board approvals, regulatory clearances, and Datavault’s operational and financial performance. The company warns there is no assurance the transaction will close on the outlined terms or at all, and notes that failure to finalize the deal—or any resulting disputes over the term sheet—could lead to costly litigation, distract management, and negatively affect Scilex’s financial condition and liquidity, adding execution risk for investors evaluating the potential strategic benefits of this AI infrastructure revenue stream.

More about Scilex Holding Company

Scilex Holding Company operates in the healthcare and biopharmaceutical sector, focusing on specialty therapeutics and pain management products. The company targets markets where non-opioid and innovative treatments can capture share from traditional therapies and address unmet medical needs among patients and providers.

Average Trading Volume: 42,752

Technical Sentiment Signal: Sell

Current Market Cap: $56.81M

Learn more about SCLX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1